The outcomes revealed a substantial enhancement in NSCLC cell migration ability upon FERMT1 overexpression, whereas migration ability was notably hindered with FERMT1 knockdown (Fig. 2A and B). Here, FERMT1 is linked to non-small cell lung carcinoma.